Sort

Search

01/01/2023 Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study
Piggott T., Moja L., Akl E.A., Lavis J.N., Cooke G., Kredo T., Hogerzeil H.V., Huttner B., Alonso-Coello P., Schünemann H.. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2023; 154DOI:10.1016/j.jclinepi.2022.12.007. PMID:36584732. IF:7.300(Q1/1D).
01/01/2023 Overview of systematic reviews of risk factors for prosthetic joint infection
Sabater-Martos M., Martínez-Pastor J.C., Morales A., Ferrer M., Antequera A., Roqué M.. Overview of systematic reviews of risk factors for prosthetic joint infection. Revista Espanola De Cirugia Ortopedica Y Traumatologia. 2023; 67(5)DOI:10.1016/j.recot.2023.04.010. PMID:37116750. IF:(Q/D).
01/01/2023 Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
Sharif S., Meader N., Oddie S.J., Rojas-Reyes M.X., McGuire W.. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Of Systematic Reviews. 2023; 2023(7)DOI:10.1002/14651858.CD005496.pub6. PMID:37493095. IF:(Q/D).
01/01/2023 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old
Roqué-Figuls M., Giné-Garriga M., Granados Rugeles C., Perrotta C., Vilaró J.. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Of Systematic Reviews. 2023; 2023(4)DOI:10.1002/14651858.CD004873.pub6. PMID:37010196. IF:(Q/D).
01/01/2023 Surgical interventions for presbyopia
Alvarado-Villacorta R., Hernandez-Quintela E., De La Torre-Gonzalez E., Loza Munárriz C., Martinez-Zapata M.J.. Surgical interventions for presbyopia. Cochrane Database Of Systematic Reviews. 2023; 2023(3)DOI:10.1002/14651858.CD015711. PMID:. IF:(Q/D).
01/01/2023 Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis
Mayoral K., Lizano-Barrantes C., Zamora V., Pont A., Miret C., Barrufet C., Caballero-Rabasco M.A., Praena-Crespo M., Bercedo A., Valdesoiro-Navarrete L., Guerra M.T., Pardo Y., Zapata M.J.M., Garin O., Ferrer M.. Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis. European Respiratory Review. 2023; 32(170)DOI:10.1183/16000617.0124-2023. PMID:37852659. IF:9.000(Q1/1D).
01/01/2023 Latin American and the Caribbean Code Against Cancer 1st edition: Weight, physical activity, diet, breastfeeding, and cancer
Aburto T.C., Romieu I., Stern M.C., Barquera S., Corvalán C., Hallal P.C., Reynales-Shigematsu L.M., Barnoya J., Cavalcante T.M., Canelo-Aybar C., Santero M., Feliu A., Espina C., Rivera J.A.. Latin American and the Caribbean Code Against Cancer 1st edition: Weight, physical activity, diet, breastfeeding, and cancer. Cancer Epidemiology. 2023; 86DOI:10.1016/j.canep.2023.102436. PMID:37852731. IF:2.400(Q2/5D).
01/01/2023 Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map
Requeijo, C, Bracchiglione, J, Meza, N, Acosta-Dighero, R, Salazar, J, Santero, M, Meade, AG, Quintana, MJ, Rodríguez-Grijalva, G, Selva, A, Solà, I, Urrútia, G, Cosp, XB. Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map. Clinical Epidemiology. 2023; 15DOI:10.2147/CLEP.S431498. PMID:38025841. IF:3.400(Q1/3D).
01/01/2023 Perioperative glycaemic control for people with diabetes undergoing surgery
Bellon, F, Solà, I, Gimenez-Perez, G, Hernández, M, Metzendorf, MI, Rubinata, E, Mauricio, D. Perioperative glycaemic control for people with diabetes undergoing surgery. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2023; 2023(8)DOI:10.1002/14651858.CD007315.pub3. PMID:37526194. IF:8.800(Q1/1D).
01/01/2023 Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening
Baena A., Paolino M., Villarreal-Garza C., Torres G., Delgado L., Ruiz R., Canelo-Aybar C., Song Y., Feliu A., Maza M., Jeronimo J., Espina C., Almonte M.. Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening. Cancer Epidemiology. 2023; 86DOI:10.1016/j.canep.2023.102446. PMID:37852728. IF:2.400(Q2/5D).
01/01/2023 Latin America and the Caribbean Code Against Cancer 1st edition: Tobacco and nicotine-related products, secondhand smoke, and alcohol and cancer
Reynales-Shigematsu L.M., Barnoya J., Cavalcante T., Aburto T.C., Romieu I., Stern M.C., Barquera S., Corvalán C., Hallal P.C., Canelo-Aybar C., Alvarado-Villacorta R., Espina C., Feliu A., Rivera J.A.. Latin America and the Caribbean Code Against Cancer 1st edition: Tobacco and nicotine-related products, secondhand smoke, and alcohol and cancer. Cancer Epidemiology. 2023; 86DOI:10.1016/j.canep.2023.102413. PMID:37852726. IF:2.400(Q2/5D).
01/01/2023 Latin America and the Caribbean Code Against cancer 1st edition: Environment, occupation, and cancer
Blanco E., Algranti E., Cifuentes L.A., López-Carrillo L., Mora A.M., Rodríguez-Guzmán J., Rodríguez-Villamizar L.A., Veiga L.H.S., Canelo-Aybar C., Nieto-Gutierrez W., Feliu A., Espina C., Ferreccio C.. Latin America and the Caribbean Code Against cancer 1st edition: Environment, occupation, and cancer. Cancer Epidemiology. 2023; 86DOI:10.1016/j.canep.2023.102381. PMID:37852723. IF:2.400(Q2/5D).
01/01/2023 Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer
Herrero R., Carvajal L.J., Camargo M.C., Riquelme A., Porras C., Ortiz A.P., Camargo L.A., Fink V., van De Wyngard V., Lazcano-Ponce E., Canelo-Aybar C., Balbin-Ramon G., Feliu A., Espina C.. Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer. Cancer Epidemiology. 2023; 86DOI:10.1016/j.canep.2023.102435. PMID:. IF:(Q/D).
01/01/2023 ¿Influyen los determinantes socioeconómicos en la oferta de los menús escolares?
Ramos Vaquero P., Font Sabaté M., Juárez Martínez O., Sánchez-Martínez F., Manera Bassols M., Blanquer Genovart M.. ¿Influyen los determinantes socioeconómicos en la oferta de los menús escolares?. Nutricion Hospitalaria. 2023; 40(4)DOI:10.20960/nh.04529. PMID:37409719. IF:(Q/D).
01/01/2023 Gender bias in pediatric care: Health professionals' opinions and perceptions
Carrilero N., Pérez-Jover V., Guilabert-Mora M., García-Altés A.. Gender bias in pediatric care: Health professionals' opinions and perceptions. Health Science Reports. 2023; 6(10)DOI:10.1002/hsr2.1615. PMID:37885465. IF:(Q/D).
01/01/2023 Marco conceptual del juego de apuestas y sus daños asociados
Sancho O., Clotas C., Bartroli M.. Marco conceptual del juego de apuestas y sus daños asociados. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:. IF:(Q/D).
01/01/2023 Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona
Porta M., Pumarega J., Gasull M., Aguilar R., Henríquez-Hernández L.A., Basagaña X., Zumbado M., Villar-García J., Rius C., Mehta S., Vidal M., Jimenez A., Campi L., Lop J., Pérez Luzardo O.L., Dobaño C., Moncunill G.. Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona. ENVIRONMENTAL RESEARCH. 2023; 223DOI:10.1016/j.envres.2023.115419. PMID:36740154. IF:7.700(Q1/1D).
01/01/2023 Hepatitis C antibody prevalence and active hepatitis C infection in HIV-negative gay, bisexual, and other men who have sex with men in Barcelona and Madrid, Spain (March 2018-March 2021)
Palma D., Alarcón M., García de Olalla P., Guerras J.-M., Pericas C., García J., Barberá M.J., Ayerdi O., Vera García M., Román-Urrestarazu A., Belza M.J., Rius C.. Hepatitis C antibody prevalence and active hepatitis C infection in HIV-negative gay, bisexual, and other men who have sex with men in Barcelona and Madrid, Spain (March 2018-March 2021). Ijid Regions. 2023; 8DOI:10.1016/j.ijregi.2023.07.001. PMID:37554356. IF:(Q/D).
01/01/2023 Latent Tuberculosis Infection in Users of Drug Dependence Care and Follow-up Centers in Barcelona in 2017–2021: A Cross-sectional Descriptive Study
Prieto García R., Millet J.P., Palma D., Barbaglia Navarro M.G., Gibert C.R.. Latent Tuberculosis Infection in Users of Drug Dependence Care and Follow-up Centers in Barcelona in 2017–2021: A Cross-sectional Descriptive Study. Open Respiratory Archives. 2023; 5(3)DOI:10.1016/j.opresp.2023.100257. PMID:37599795. IF:(Q/D).
01/01/2023 The challenge of therapy adherence in clinical practice
Brotons, C. The challenge of therapy adherence in clinical practice. European Journal of Preventive Cardiology. 2023; 30(2)DOI:10.1093/eurjpc/zwac197. PMID:36062950. IF:8.600(Q1/1D).